The main areas of technological advancement, such as 5G, do not seem to be synonymous with green energy and can even frighten the most resistant. However, it is now possible to reconcile reliable and sustainable power with the increasingly strong demand for energy. How do we balance the various loads to grid and the amount of available power to maximize efficiencies? How will industries and households meet these expectations? Our Construction & Energy teams support the future of new energies in the US: net zero emissions, investments in solar and battery equipment storage, wind farms or local production of individual electricity. Isabelle has worked 25 years in the Construction world. She has en Engineering degrees obtained from Ecole Polytechnique and Ecole des Ponts et Chaussées in Paris. She joined the insurance industry in 2001 as Construction Facultative underwriter with SCOR Business Solutions, managing strong lead placements around the world and developing the Engineering portfolio. She then developed in depth knowledge and practice of direct insurance through 8 years as Senior Underwriter and Practice leader at AXA Corporate Solutions in Paris. She is now back to SCOR Specialty Insurance as Global Head of Construction based in Zürich. Matthew is based in NYC. He arrived at SCOR six years ago as Manager for the North America Construction team. Prior to this, he was Vice-President for the Underwriting Energy & Construction team at Liberty and for the Property Facultative team at Swiss Re. He has a Bachelor degree in Finance from the Xavier University - William College of Business, Cincinnati. John Torres joined the SCOR Power & Energy Underwriting Team in Houston last January 2021. John started his career at Starr Insurance Companies as an Energy, Power Gen, and Construction Underwriter for over 6 years, his last position was Senior Underwriter for Latin America. He graduated with a Master's in Industrial Engineering from Texas A&M University.

With the rise of Big Data and the proliferation of data sources, companies have more and more data at their disposal. IoT and all the new technologies make it possible to collect a large amount of data. How to sort, classify and exploit them? Analytical technologies are more and more accessible and make it possible to take advantage of this data in order to create the most precise modeling solutions. Avoca Insurance Holdings is a privately held, independent company founded in Bermuda in January 2009. The company was established to start up, own, and operate highly specialized underwriting management companies. SCOR works jointly with Avoca to combine highly experienced underwriting talent with purpose-built technology and strong portfolio management controls. Danny joined Avoca at its foundation in January 2009 as CTO and has driven the development of ground breaking insurtech since then. In 2014, Danny joined the Avoca Holding Company board and with effect from Jan 1st 2018, Danny was appointed group COO in addition to his CTO role with responsibility for all group operations as well as technology development. In March 2021, Danny was appointed President of Avondale (a Avoca subsidiary) while maintaining his other duties for the Avoca Group. Derek is SVP Natural Catastrophe Manager of The Americas, he is specialized in Catastrophe Modeling - RMS, AIR, Statistical Analysis, databases, software development, networks. He arrived in SCOR seven years ago. Prior to this, he spent 5 years at Ascot Group as VP Exposure Management. Derek has a Master degree in Management Information Systems from the Northern Illinois University, and is still based in Chicago. Rob is also based in Chicago. He began his career with SCOR as Senior Vice President, Chief Pricing Actuary - Americas in 2015. He is today Senior Vice President Head of Innovation for SCOR’s Pricing & Modeling team. Prior to SCOR, he worked as Vice President Chief Pricing Actuary / Head of Agriculture Practice for Navigators Re. He graduated with a Bachelor in Mathematics and Political Science from the Northwestern University.

In this episode, we are talking to Chris Rehse, founder and and CEO of Neotiv. Founded in 2017, neotiv has developed a digital assistant to monitor and aid the memory of patients with Dementia and Alzheimer's and focuses on improving the early detection of these conditions to facilitate efficacy monitoring, new therapies, and early intervention and prevention of brain health. Relevant for medical underwriting and post-purchase prevention and intervention measures, neotiv's medical platform presents cognitive tests to track cognitive changes in memory and visual information over time. The company also focuses on research, diagnostics and drug development for these conditions.

What if AI and Big Data meet foresight? Praedicat in partnership with SCOR, offers a forward looking emerging risk model. Through this podcast we are going to understand how this tool works and how it can help our Casualty team to develop their relationship with the clients. Why is there a lag in the casualty catastrophe models compared to the property market? What are the main advantages from a casualty underwriting perspective but also from a claim perspective? The time savings and risk reduction enabled by Praedicat also make it possible to start new conversations and projects with clients. Maura Haynes, a US citizen and Argentinian, joined SCOR in 2016 and was promoted to US GL Team Leader in 2019. She has over 20 years of experience in the insurance and reinsurance industry. Prior to SCOR, Maura worked at Swiss Re in various underwriting capacities. Maura graduated from Central Michigan University with a bachelor’s degree in Business Administration. She has also achieved an MBA from Northwood University. Steven Strauss has been appointed as US Deputy Team Leader for Casualty. Before 2014, Steven was the Vice President of Business Development at Berkley Program Specialists. He was responsible for the generation of new business and the continuing development of existing relationships with a growing portfolio of Program Administrators. Steven is gaduated from Lake Forest College, in Illinois. Emale Laurant is Vice President, Accumulation Team Lead for the Global Casualty lines related to the processes ranging from supporting the Global and Legal Entity accumulations of risks. He has been working at SCOR for 5 years, before he was Risk Actuary at AIG and XL Group. Emale is graduated from Trinity College-Hartford, Connectitut, with a BS Degree option Mathematics and Chemistry.

Global fertility has been declining at a fast pace. From 1990 to 2019, the fertility rate fell from 3.2 to 2.5 live births per woman. We are talking to Pascal Koenig, co-founder and board member of Ava about tackling infertility with science. Ava is clinically proven to identify both the opening and closing of the fertile window, letting you know your five best days to try for a baby. In a world where fertility is falling due to lower childhood mortality rates, access to birth control, and focus on career development for women and men, one in seven couples may have difficulties conceiving. With medical treatments being considerably expensive, Swiss startup Ava has created a wearable to identify a woman’s fertile window based on 3 million biomarkers.

Did you know that in Latin America, for every thousand individuals, there are only two physicians? Imagine you are at home, feeling terribly sick but having no access to medical care. Colombian startup 1DOC3 is tackling this exact situation as the largest telemedicine provider in Latin America. There is no more Doctor Google. Today we are talking to Javier Cardona, co-founder, and CEO of 1DOC3. How does it work? 1DOC3 is connecting doctors with people who have health related questions with their AI-driven symptom checker and chat. With over 1.5 million users and 300.000 consults every month, 1DOC3's digital health platform providers individualised medical information to Spanish speakers in countries like Colombia and Mexico.

ESG, CSR, two terms that we hear more and more in our personal and professional lives. What do they stand for and why are they so important today in business strategies? Paul Nunn, Senior Advisor in charge of ESG strategy for SCOR P&C, introduces and differentiates these themes, with examples and use cases. He then explains the various innovations and trends that we will face in the near future from sustainable and social aspects, and with a focus on the (re)insurance industry. Green hydrogen, wind farms, energy efficiency, carbon capture, etc. If you are not yet comfortable with these topics, find out what they could bring to your business in this 15min podcast. Before his current position, Paul was responsible for pricing catastrophe risk on inwards business, and accumulation of catastrophe loss potential for natural hazard perils globally. Alongside his role at SCOR P&C, Paul is a director of the non-profit Oasis Loss Modelling Framework company, an open source platform for developing, deploying and executing catastrophe models. He is also actively participating in the Insurance Development Forum working group on Risk Modelling & Mapping, which seeks to improve global understanding and quantification of disaster risk, particularly in developing countries.

With a population of 1.4 billion people, China has seen half a century of rapid growth as the second largest economy in the world. Despite 95% of the population has basic health insurance coverage, many are turning to private health insurance, a market estimated to exceed spending of one trillion dollars in 2020. Today we are talking to Sebastien Gaudin, co-founder, and CEO of The Carevoice, a tech-driven startup which has created a healthcare operating system which connects insurers, pharmacies, physicians, hospitals and care providers, and the pharma industry to care and cure patients. As you will hear, Sebastian and I faced the challenges of working from home, so the quality of the call reflects this. We hope you enjoy the episode.

Will Thorne, Will Bird and Dana Cullen of P&C Ventures host this week’s SCOR Innovation Podcast, discussing the team’s origins, investment theses, activities and the launch of their new three year strategy: Ventures 2.0. Will Thorne is the Head of P&C Ventures. Will has a background in both (re)insurance underwriting and start-ups. He is a frequent advisor & angel investor in his personal capacity and was the founding chair of the UK Insurtech Board. Will Bird is an Associate based in Chicago. Will focuses on investment & partnership opportunities in the Americas. His previous experience includes corporate venture capital and strategy at a leading U.S. personal lines insurer. Dana Cullen is an Innovation Associate based in London. Dana has a background in actuarial pricing and epidemiology, having previously worked for SCOR Global Life, and focuses on the development and execution of Insurtech MGA/carrier partnerships.

The mean cost of developing a new drug has been the subject of debate for many years. A recent study conducted by the London School of Economics estimates a range from 314 million USD to 2.8 billion. And despite the costs varying across different disease areas, it is still a pricey and very lengthy process. In today's episode, we are talking to Tamás Görbe, co-founder and CSO of Menten.AI. Known as one of the most notorious startups using quantum computing in drug research and development. Backed by Y Combinator in 2020, the American startup accelerator which launched Airbnb or Dropbox. The startup uses machine learning and quantum computing to create the next generation of protein-based drugs and enzymes focused on rare diseases, neurological disorders, or viruses.